November 15, 2013

A Food and Drug Administration expert panel has voted to recommend approval for a drug to treat a circadian rhythm disorder that affects most people with total blindness.

November 15, 2013

The Food and Drug Administration has approved a new drug for fungal infections of the skin made by Valeant Pharmaceuticals International, the drug maker said Friday.

November 15, 2013

The Food and Drug Administration has approved an OTC personal lubricant that helps couples conceive more easily.

November 15, 2013

The Food and Drug Administration has given orphan drug designation to an experimental treatment for a rare form of epilepsy.

November 15, 2013

The value of drugs approved in the United States this year could reach almost $19 billion in sales five years after their launch, exceeding the value of drugs approved in 2012, according to a new report.

November 14, 2013

The Food and Drug Administration has requested label and packaging changes of certain over-the-counter topical antiseptic products, according to an FDA MedWatch alert.

November 13, 2013

The Food and Drug Administration has approved a new drug for treating a rare and aggressive type of blood cancer, the agency said Wednesday.

November 13, 2013

Johnson & Johnson and Pharmacyclics have added a New York-based specialty pharmacy company focused on cancer to their limited-distribution network for a drug recently approved for a rare form of blood cancer.

November 13, 2013

The chairman of the Senate Health, Education, Labor and Pensions Committee highlighted the human tragedy wrought by last year's fungal meningitis outbreak linked to contaminated injectable steroids as he spoke in favor of a new law that would regulate compounding pharmacies and also implement federal track-and-trace policies for drugs during a recent speech.

November 13, 2013

Sohm on Tuesday announced the U.S. launch of its umbrella brand SohMed, positioning the company in the generic over-the-counter medicines segment for indications of pain, fever, cold, antacid and alertness.

November 11, 2013

The Food and Drug Administration on Sunday announced that USPlabs of Dallas is recalling certain OxyElite Pro dietary supplement products that the company markets.

November 11, 2013

Mylan has launched its generic version of a drug used to treat gastroesophageal reflux disease, the U.S.-based generic drug maker said Monday.

November 11, 2013

In terms of boosting medication adherence and prescription volumes, the benefits of consolidating all of a patient’s prescriptions into a single, once-a-month refill process are even greater than previously thought.

November 8, 2013

Generic drug maker Amneal Pharmaceuticals will launch its version of a contraceptive product at the beginning of January, the drug maker said.

November 8, 2013

Sanofi-Aventis has sued the Food and Drug Administration to keep its labeling for OTC Nasacort confidential in an effort to delay store brand competition until after the launch, according to an entry in the FDA Law Blog, the official blog of Hyman, Phelps & McNamara, published Thursday.

November 8, 2013

The Food and Drug Administration has approved a new drug for treating epileptic seizures, the agency said Friday.

November 8, 2013

When the maker of a branded drug updates the safety information on its product labeling, makers of generic versions of that drug must wait until the Food and Drug Administration approves the new labeling before they can update theirs, but that could soon change under a rule proposed by the FDA.

November 8, 2013

It’s called medication synchronization, and the concept is simple enough — shifting patients to a synchronized, easy-to-comply-with, once-a-month prescription refill program so they can pick up all their medications with one visit to the pharmacy each month, instead of multiple trips.

November 8, 2013

Like any company looking to stage a turnaround, Rite Aid has employed multiple tactics to return to profitability and win back investors’ favor, but few of those programs have been as important to the chain’s efforts as its loyalty card program.

November 8, 2013

The Senate this past week heard legislation that would reverse the provision of the Patient Protection and Affordable Care Act mandating a prescription on the sale of an over-the-counter medicine being paid for through a flexible spending account. All those in the retail pharmacy industry are staunch supporters of the legislation.

And that's because retail pharmacy gets it. It's not about the sales — has anyone ever heard of a consumer who decided not to purchase a pain reliever or cough syrup because it wasn't an eligible FSA purchase without a trip to their doctor? No. That person doesn't exist — they'll buy the same amount of OTCs to cure what's ailing them with an FSA as without an FSA. No, it's about the value inherent within OTCs. It's about tapping into that value to the benefit of both consumers and overall health care.

November 8, 2013

The United States is leading in its preference for generic drugs. According to a new report by Rhinebeck, N.Y.-based Phoenix Marketing International, 37% of American consumers expressed a preference for generic drugs when they were available, compared with 22% of the French, 21% of Canadians and 12% of Britons. The study was based on 810 consumers in the four countries.

November 8, 2013
Higi ‘scores’ with kiosks

Through its biometric screening kiosks, its smartphone application and its website, Higi encourages users to take a more holistic approach to their health. True wellness, its creators insist, springs not just from such physical metrics as blood pressure, glucose readings and body mass index, but from lifestyle choices and connections to family, friends, neighbors and coworkers.

November 7, 2013

Aisle7 on Thursday announced the launch of Healthnotes Interactions Checker, a next-generation solution simplifying the task of deciding which nutrients positively or negatively interact with the medicines they take.

November 6, 2013

State legislators in Michigan are considering a bill that would allow pharmacies to sell medical marijuana, according to published reports.